This sleeve allocates to listed Nordic healthcare companies in biotechnology, medtech, diagnostics, and specialized services. Holdings emphasize focused product lines, niche leadership, and advancing pipelines. The priority is high-quality growth supported by durable moats, recurring revenue, and capital-efficient reinvestment to enable long-term compounding across subsectors.
Updated 2025-10-30